ArticleThe European journal of neuroscience2024

Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.

Katherine R Brimblecombe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.